Table 1.

Patient characteristics

Parameter*		Chronic myocardial infarction (N = 30)			Left ventricular hypertrophy (N = 46)
Subgroup	Healthy volunteers	Focal fibrosis, no WMA and preserved LVEF	Focal fibrosis, regional WMA and reduced LVEF	Focal fibrosis, global WMA and dilated LV with reduced LVEF	Arterial hypertension	Aortic stenosis	Hypertrophic cardiomyopathy
N =	60	10	10	10	8	24	14
Gender (F/M)	26/34	4/6	1/9	0/10	4/4	7/17	3/11
Scanner (1.5 T/3 T)	36/24	10/0	10/0	10/0	8/0	14/10	12/2
Age (years)	44.1 ± 16.4	71.2 ± 8.5	68.6 ± 11.4	57.9 ± 12.3	64.0 ± 12.7	77.4 ± 7.5	48.4 ± 7.9
Height (cm)	173.8 ± 8.4	172.0 ± 9.2	174.6 ± 6.4	180.6 ± 7.5	172.5 ± 10.3	169.0 ± 8.1	178.2 ± 5.9
Weight (kg)	74.1 ± 12.4	76.5 ± 15.7	84.3 ± 9.6	92.9 ± 21.7	85.6 ± 14.6	86.1 ± 13.0	89.4 ± 7.0
BMI (kg/m2)	24.5 ± 3.8	25.6 ± 3.6	27.7 ± 3.3	28.3 ± 5.5	29.0 ± 6.0	29.3 ± 4.8	28.1 ± 1.6
BSA (m2)	1.9 ± 0.2	1.9 ± 0.2	2.0 ± 0.1	2.1 ± 0.3	2.0 ± 0.2	2.0 ± 0.2	2.1 ± 0.1
LVEDV (mL)	144.9 ± 30.8	163.0 ± 39.8	175.5 ± 59.1	303.3 ± 82.0	171.8 ± 55.1	150.1 ± 36,9	163.4 ± 32.8
LVESV (mL)	60.4 ± 17.5	77.5 ± 24.5	100.1 ± 53.1	236.6 ± 73.1	75.5 ± 27.3	63.9 ± 18.3	62.7 ± 13.6
LVSV (mL)	84.5 ± 17.2	85.4 ± 21.9	75.3 ± 13.5	66.7 ± 19.6	96.3 ± 29.1	86.2 ± 25.3	100.8 ± 25.4
LVEF (%)	58. 7 ± 6.1	52.9 ± 7.6	45.4 ± 13.5	22.6 ± 5.3	56.4 ± 4.0	57.3 ± 8.1	61.2 ± 6.4
LVM (g)	88.6 ± 20.1	114.5 ± 24.8	124.7 ± 20.3	162.9 ± 33.5	154.5 ± 58.2	136.7 ± 40.2	153.2 ± 52.8

WMA wall motion abnormalities, LV left ventricle, LVEF left ventricular ejection fraction, BMI body mass index, BSA body surface area, LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, LVSV left ventricular stroke volume, LVM left ventricular mass; *data represented as frequencies for categorical variables and as mean ± standard deviation for continuous variables